218 related articles for article (PubMed ID: 21030485)
1. Cytochrome P450 2J2 is highly expressed in hematologic malignant diseases and promotes tumor cell growth.
Chen C; Wei X; Rao X; Wu J; Yang S; Chen F; Ma D; Zhou J; Dackor RT; Zeldin DC; Wang DW
J Pharmacol Exp Ther; 2011 Feb; 336(2):344-55. PubMed ID: 21030485
[TBL] [Abstract][Full Text] [Related]
2. Cytochrome P450 2J2 promotes the neoplastic phenotype of carcinoma cells and is up-regulated in human tumors.
Jiang JG; Chen CL; Card JW; Yang S; Chen JX; Fu XN; Ning YG; Xiao X; Zeldin DC; Wang DW
Cancer Res; 2005 Jun; 65(11):4707-15. PubMed ID: 15930289
[TBL] [Abstract][Full Text] [Related]
3. Selective inhibitors of CYP2J2 related to terfenadine exhibit strong activity against human cancers in vitro and in vivo.
Chen C; Li G; Liao W; Wu J; Liu L; Ma D; Zhou J; Elbekai RH; Edin ML; Zeldin DC; Wang DW
J Pharmacol Exp Ther; 2009 Jun; 329(3):908-18. PubMed ID: 19289568
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450 2J2 is protective against global cerebral ischemia in transgenic mice.
Li R; Xu X; Chen C; Yu X; Edin ML; Degraff LM; Lee CR; Zeldin DC; Wang DW
Prostaglandins Other Lipid Mediat; 2012 Dec; 99(3-4):68-78. PubMed ID: 23041291
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome p450 epoxygenase promotes human cancer metastasis.
Jiang JG; Ning YG; Chen C; Ma D; Liu ZJ; Yang S; Zhou J; Xiao X; Zhang XA; Edin ML; Card JW; Wang J; Zeldin DC; Wang DW
Cancer Res; 2007 Jul; 67(14):6665-74. PubMed ID: 17638876
[TBL] [Abstract][Full Text] [Related]
6. Cytochrome P450 Epoxygenase 2J2 Protects Against Lung Ischemia/Reperfusion Injury by Activating the P13K/Akt/GSK-3-β/NF-kB Signaling Pathway During Deep Hypothermic Low Flow in Mice.
Yang Y; Wang J; Peng W; Shu Y; Mo X
J Surg Res; 2020 Sep; 253():8-17. PubMed ID: 32305498
[TBL] [Abstract][Full Text] [Related]
7. EETs and CYP2J2 inhibit TNF-α-induced apoptosis in pulmonary artery endothelial cells and TGF-β1-induced migration in pulmonary artery smooth muscle cells.
Feng W; Xu X; Zhao G; Li G; Liu T; Zhao J; Dong R; Wang DW; Tu L
Int J Mol Med; 2013 Sep; 32(3):685-93. PubMed ID: 23835530
[TBL] [Abstract][Full Text] [Related]
8. CYP2J2 and EETs Protect against Oxidative Stress and Apoptosis in Vivo and in Vitro Following Lung Ischemia/Reperfusion.
Chen W; Zheng G; Yang S; Ping W; Fu X; Zhang N; Wang DW; Wang J
Cell Physiol Biochem; 2014; 33(6):1663-80. PubMed ID: 24903033
[TBL] [Abstract][Full Text] [Related]
9. CYP2J2
Tao P; Jiang Y; Wang H; Gao G
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2021 Sept 28; 46(9):932-941. PubMed ID: 34707002
[TBL] [Abstract][Full Text] [Related]
10. Effects of cytochrome P450 arachidonic acid epoxygenases on the proliferation of tumor cells.
Jiang JG; Shen GF; Chen C; Fu XN; Wang DW
Ai Zheng; 2009 Jan; 28(1):14-9. PubMed ID: 19448409
[TBL] [Abstract][Full Text] [Related]
11. CYP2J2 attenuates metabolic dysfunction in diabetic mice by reducing hepatic inflammation via the PPARγ.
Li R; Xu X; Chen C; Wang Y; Gruzdev A; Zeldin DC; Wang DW
Am J Physiol Endocrinol Metab; 2015 Feb; 308(4):E270-82. PubMed ID: 25389363
[TBL] [Abstract][Full Text] [Related]
12. CYP2J2-derived EETs attenuated ethanol-induced myocardial dysfunction through inducing autophagy and reducing apoptosis.
Zhou C; Huang J; Li Q; Zhan C; Xu X; Zhang X; Ai D; Zhu Y; Wen Z; Wang DW
Free Radic Biol Med; 2018 Mar; 117():168-179. PubMed ID: 29427791
[TBL] [Abstract][Full Text] [Related]
13. CYP2J2 promotes the development of hepatocellular carcinoma by increasing the EETs production to improve HIF-1α stability.
Gui L; Xu Q; Huang J; Wu G; Tang H; Hui L; Hua P; Zhang L; Zhu Y
Am J Transl Res; 2020; 12(12):7923-7937. PubMed ID: 33437370
[TBL] [Abstract][Full Text] [Related]
14. Delivery of AAV2-CYP2J2 protects remnant kidney in the 5/6-nephrectomized rat via inhibition of apoptosis and fibrosis.
Zhao G; Tu L; Li X; Yang S; Chen C; Xu X; Wang P; Wang DW
Hum Gene Ther; 2012 Jul; 23(7):688-99. PubMed ID: 22260463
[TBL] [Abstract][Full Text] [Related]
15. Endothelium-specific CYP2J2 overexpression attenuates age-related insulin resistance.
Yang Y; Dong R; Chen Z; Hu D; Fu M; Tang Y; Wang DW; Xu X; Tu L
Aging Cell; 2018 Apr; 17(2):. PubMed ID: 29318723
[TBL] [Abstract][Full Text] [Related]
16. Cytochrome P450 2J2: distribution, function, regulation, genetic polymorphisms and clinical significance.
Xu M; Ju W; Hao H; Wang G; Li P
Drug Metab Rev; 2013 Aug; 45(3):311-52. PubMed ID: 23865864
[TBL] [Abstract][Full Text] [Related]
17. CYP2J2 overexpression attenuates nonalcoholic fatty liver disease induced by high-fat diet in mice.
Chen G; Xu R; Zhang S; Wang Y; Wang P; Edin ML; Zeldin DC; Wang DW
Am J Physiol Endocrinol Metab; 2015 Jan; 308(2):E97-E110. PubMed ID: 25389366
[TBL] [Abstract][Full Text] [Related]
18. Cytochrome P450 (CYP) 2J2 gene transfection attenuates MMP-9 via inhibition of NF-kappabeta in hyperhomocysteinemia.
Moshal KS; Zeldin DC; Sithu SD; Sen U; Tyagi N; Kumar M; Hughes WM; Metreveli N; Rosenberger DS; Singh M; Vacek TP; Rodriguez WE; Ayotunde A; Tyagi SC
J Cell Physiol; 2008 Jun; 215(3):771-81. PubMed ID: 18181170
[TBL] [Abstract][Full Text] [Related]
19. Plant natural product plumbagin presents potent inhibitory effect on human cytochrome P450 2J2 enzyme.
Lu J; Liu D; Zhou X; Chen A; Jiang Z; Ye X; Liu M; Wang X
Phytomedicine; 2018 Jan; 39():137-145. PubMed ID: 29433675
[TBL] [Abstract][Full Text] [Related]
20. CYP2J2 and EETs protect against lung ischemia/reperfusion injury via anti-inflammatory effects in vivo and in vitro.
Chen W; Yang S; Ping W; Fu X; Xu Q; Wang J
Cell Physiol Biochem; 2015; 35(5):2043-54. PubMed ID: 25870948
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
